Insider · CIK 0001819880
Jens Holstein
director
Files at VCYT (VERACYTE, INC.). First filing Nov 21, 2025, latest Sep 16, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $628k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VCYT: VERACYTE, INC.
VCYTOct 9, 2026 · close 45.23
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 27Weak | VERACYTE, INC. | $205k 5,000 shares | -15% | +37% from low-32% from high | |
| 36Weak | VERACYTE, INC. | $424k 10,000 shares | -27% | +77% from low-11% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | VCYT VERACYTE, INC. | SOpen-market sale Common Stock10b5-1 | -5,000 | $40.95 | $205k | 27,471 | 26 d ago |
| Nov 20, 2025 | VCYT VERACYTE, INC. | SOpen-market sale Common Stock10b5-1 | -1,491 | $40.95 | $61k | 35,708 | Nov 21, 2025 |
| Nov 20, 2025 | VCYT VERACYTE, INC. | SOpen-market sale Common Stock10b5-1 | -7,049 | $42.48 | $299k | 28,659 | Nov 21, 2025 |
| Nov 20, 2025 | VCYT VERACYTE, INC. | SOpen-market sale Common Stock10b5-1 | -1,460 | $43.21 | $63k | 27,199 | Nov 21, 2025 |
| Jun 18, 2025 | VCYT VERACYTE, INC. | AGrant or award Common Stock | +9,321 | $0.00 | $0 | 37,199 | Jun 23, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.